DTC Ads Must Be "Clear And Balanced" Under Sen. Edwards Bill
This article was originally published in The Pink Sheet Daily
The legislation is similar to an amendment Edwards proposed for the Medicare Rx bill. It also calls for NIH comparative efficacy studies and an expedited drug advertisement review process.
You may also be interested in...
Sen. Edwards is an advocate of stricter DTC regulation, generic patent law reform, comparative effectiveness research and DoJ investigation of manufacturer “price gouging.”
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.